Literature DB >> 12601223

Getting what you ask for: on the selectivity of depression rating scales.

Koen Demyttenaere1, Jürgen De Fruyt.   

Abstract

A large number of rating scales has been developed to assess depression severity and change during antidepressant therapy. When reviewing the literature, the choice of the rating scales used in a particular study often seems arbitrary. The most frequently used observer rating scales, the Hamilton Depression Rating Scale (HDRS) and the Montgomery-Asberg Depression Rating Scale (MADRS), and the most frequently used self-rating scale (the Beck Depression Inventory, or BDI) were developed more than 20 years ago. Their historical background is too often forgotten and they are reflections of their origin: the HDRS and the MADRS reflect antidepressant activity while the BDI reflects psychotherapy. Moreover, the HDRS is at risk of putting 'all depressions in one basket', while the MADRS is at risk of putting 'all antidepressants in one basket'. Therefore, the question whether a particular antidepressant could be more effective in a particular subtype of depression cannot be answered. Observer rating scales are more frequently used than self-rating scales, and when scales are used that do exist in an observer rating and a self-rating version, interesting differences are found. The present paper does not suggest that one scale is better than another, but suggests that a better knowledge of their differential background can help the researcher choose the correct scale for his purposes. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601223     DOI: 10.1159/000068690

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  42 in total

1.  Relationships among adaptive and maladaptive emotion regulation strategies and psychopathology during the treatment of comorbid anxiety and alcohol use disorders.

Authors:  Laren R Conklin; Clair Cassiello-Robbins; C Alex Brake; Shannon Sauer-Zavala; Todd J Farchione; Domenic A Ciraulo; David H Barlow
Journal:  Behav Res Ther       Date:  2015-08-10

Review 2.  Social functioning: should it become an endpoint in trials of antidepressants?

Authors:  Per Bech
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practice.

Authors:  Thomas Messer; Max Schmauss; Judith Lambert-Baumann
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Efficacy evaluation of exercise as an augmentation strategy to brief behavioral activation treatment for depression: a randomized pilot trial.

Authors:  Kristin L Szuhany; Michael W Otto
Journal:  Cogn Behav Ther       Date:  2019-07-30

5.  Validity of the definite and semidefinite questionnaire version of the Hamilton Depression Scale, the Hamilton Subscale and the Melancholia Scale. Part I.

Authors:  Jesper Bent-Hansen; Per Bech
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-03-02       Impact factor: 5.270

6.  Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol.

Authors:  Saray Monzón; Margalida Gili; Margalida Vives; Maria Jesus Serrano; Natalia Bauza; Rosa Molina; Mauro García-Toro; Joan Salvà; Joan Llobera; Miquel Roca
Journal:  BMC Psychiatry       Date:  2010-06-17       Impact factor: 3.630

7.  Dimensional and hierarchical models of depression using the Beck Depression Inventory-II in an Arab college student sample.

Authors:  Fawziyah A Al-Turkait; Jude U Ohaeri
Journal:  BMC Psychiatry       Date:  2010-07-29       Impact factor: 3.630

8.  Establishing a common metric for depressive symptoms: linking the BDI-II, CES-D, and PHQ-9 to PROMIS depression.

Authors:  Seung W Choi; Benjamin Schalet; Karon F Cook; David Cella
Journal:  Psychol Assess       Date:  2014-02-17

9.  Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder.

Authors:  Monika Talarowska; Piotr Gałecki; Michael Maes; Kinga Bobińska; Edward Kowalczyk
Journal:  Neurochem Res       Date:  2012-05-05       Impact factor: 3.996

10.  Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder.

Authors:  Koen Demyttenaere; Durisala Desaiah; Claude Petit; Jens Croenlein; Stephan Brecht
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.